Longitudinal profiling of tumor-reactive T cells during TIL therapy in metastatic melanoma
Michael T. Sandholzer, Clara Serger, Alessia G Liner, Sarp Uzun, David König, Helen Thut, Reto Ritschard, Jonas D. Fürst, Andreas Zingg, Natália Rodrigues Mantuano, Benjamin Kasenda, Katharina Glatz, Elisabeth A. Kappos, Matthias Sebastian Matter, Andreas Holbro, , Heinz Philipp Laubli
This study profiles tumor-reactive T cell dynamics during TIL therapy in metastatic melanoma, identifying factors associated with response and resistance.
bioRxiv · Sep 23, 2025 · PreprintImmunology